115 related articles for article (PubMed ID: 22197545)
1. Up-regulation of Notch-1 in psoriasis: an immunohistochemical study.
Abdou AG; Maraee AH; Sharaf A; Elnaidany NF
Ann Diagn Pathol; 2012 Jun; 16(3):177-84. PubMed ID: 22197545
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D expression in chronic plaque psoriasis: an immunohistochemical study.
Abdou AG; Maraee AH; Shoeib MA; Elsammie AA; Elnaidany NF
Acta Dermatovenerol Croat; 2011; 19(3):143-9. PubMed ID: 21933637
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
Abdou AG; Hanout HM
J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
[TBL] [Abstract][Full Text] [Related]
4. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N
Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
[TBL] [Abstract][Full Text] [Related]
7. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
Seleit I; Bakry OA; Abdou AG; Dawoud NM
Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis.
El-Domyati M; Moftah NH; Nasif GA; Abdel-Wahab HM; Barakat MT; Abdel-Aziz RT
Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):18-26. PubMed ID: 23281693
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.
Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M
Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373
[TBL] [Abstract][Full Text] [Related]
11. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
12. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
Oxholm A; Oxholm P; Staberg B; Bendtzen K
Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
[TBL] [Abstract][Full Text] [Related]
14. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
15. Perforin expression is upregulated in the epidermis of psoriatic lesions.
Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424
[TBL] [Abstract][Full Text] [Related]
16. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt.
Amin MM; Azim ZA
Indian J Pathol Microbiol; 2012; 55(1):56-60. PubMed ID: 22499302
[TBL] [Abstract][Full Text] [Related]
19. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis.
Bhawan J; Bansal C; Whren K; Schwertschlag U;
J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein before and after PUVA treatment in psoriasis.
Hannuksela-Svahn A; Pääkkö P; Autio P; Reunala T; Karvonen J; Vähäkangas K
Acta Derm Venereol; 1999 May; 79(3):195-9. PubMed ID: 10384915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
